Largest biotech by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

CG Oncology has the lowest figure of the 11 biotech ranked by total debt, at CHF 2.5M, followed by Scholar Rock Holding (CHF 84M) and Adaptive Biotechnologies (CHF 110.6M). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
Lowest
CG OncologyCHF 2.5M
Median
CHF 497.2M
Combined market value
CHF 707B
Countries
5
Not ranked
13no total debt on file

Market values as of .

Largest biotech by total debt
#CompanyTotal debt ↑Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health CareCHF 2.5MCHF 6BCHF 67.03 0.77% up 85% up United States
2Scholar Rock HoldingSRRK · Health CareCHF 84MCHF 4.9BCHF 39.88 4.99% up 14% up United States
3Adaptive BiotechnologiesADPT · Health CareCHF 110.6MCHF 3.8BCHF 23.69 1.33% down 88% up United States
4Bio-TechneTECH · Health CareCHF 168.5MCHF 9.6BCHF 61.28 0.13% up 26% up United States
5RepligenRGEN · Health CareCHF 456.9MCHF 9.2BCHF 143.63 5.10% up 5% up United States
6ModernaMRNA · Health CareCHF 497.2MCHF 68.5BCHF 169.22 2.89% down 755% up United States
7QiagenQGEN · Health CareCHF 1.4BCHF 8.6BCHF 41.77 0.36% down 12% up Netherlands
8Halozyme TherapeuticsHALO · Health CareCHF 1.8BCHF 9.3BCHF 81.61 0.91% up 37% up United States
9BiogenBIIB · Health CareCHF 5.3BCHF 31.1BCHF 210.13 0.57% down 49% up United States
10Gilead SciencesGILD · Health CareCHF 21BCHF 176.2BCHF 142.04 1.00% down 33% up United States
11AmgenAMGN · Health CareCHF 46BCHF 203.8BCHF 376.71 2.38% down 34% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8427 CHF). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech have the lowest total debt?

CG Oncology (CHF 2.5M), Scholar Rock Holding (CHF 84M) and Adaptive Biotechnologies (CHF 110.6M) have the lowest total debt of the 11 biotech ranked here as of 18 Nov 2026, 16:15 UTC.

How many biotech are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 11 biotech ranked by total debt have a combined market value of CHF 707B as of 18 Nov 2026, 16:15 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.